Annual review of medicineHumansGlucagon-Like Peptide-1 Receptor AgonistsCardiovascular DiseasesHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor
Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Disease.
Tatsuro Ibe, Barry A Borlaug
Published: 202610.1146/annurev-med-043024-011141
Abstract
Glucagon-like peptide 1 receptor (GLP-1R) agonists were originally developed as treatments for diabetes and subsequently evolved into weight management medications. These drugs have recently been shown to demonstrate remarkable efficacy in cardiovasc…
Preview only. Read the full abstract at the source